484 related articles for article (PubMed ID: 9686590)
21. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
[TBL] [Abstract][Full Text] [Related]
22. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
23. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
Sano Y; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
[TBL] [Abstract][Full Text] [Related]
24. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
Benichou G; Valujskikh A; Heeger PS
J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
[TBL] [Abstract][Full Text] [Related]
25. Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities.
Whitby EH; Sparshott SM; Bell EB
Immunology; 1990 Jan; 69(1):78-84. PubMed ID: 2138126
[TBL] [Abstract][Full Text] [Related]
26. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection.
Bradley JA; Mowat AM; Bolton EM
Immunol Today; 1992 Nov; 13(11):434-8. PubMed ID: 1362058
[TBL] [Abstract][Full Text] [Related]
27. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
[TBL] [Abstract][Full Text] [Related]
28. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
Rosenberg AS; Katz SI; Singer A
J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
[TBL] [Abstract][Full Text] [Related]
29. Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival.
Singh NP; Guo L; Que X; Shirwan H
Xenotransplantation; 2004 Jan; 11(1):33-42. PubMed ID: 14962291
[TBL] [Abstract][Full Text] [Related]
30. Assessment of alloreactive T cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T cell-mediated rejection response declines with advanced age.
Rosenberg AS; Sechler JM; Horvath JA; Maniero TG; Bloom ET
Eur J Immunol; 1994 Jun; 24(6):1312-6. PubMed ID: 7911422
[TBL] [Abstract][Full Text] [Related]
31. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
Dalchau R; Fangmann J; Fabre JW
Eur J Immunol; 1992 Mar; 22(3):669-77. PubMed ID: 1547813
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
Watschinger B; Gallon L; Carpenter CB; Sayegh MH
Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
[TBL] [Abstract][Full Text] [Related]
33. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
Gracie JA; Bolton EM; Porteous C; Bradley JA
J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
[TBL] [Abstract][Full Text] [Related]
34. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
Lowry RP; Gurley KE
Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
[TBL] [Abstract][Full Text] [Related]
35. Specific B cell tolerance is induced by cyclosporin A plus donor-specific blood transfusion pretreatment: prolonged survival of MHC class I disparate cardiac allografts.
Yang CP; Shittu E; Bell EB
J Immunol; 2000 Mar; 164(5):2427-32. PubMed ID: 10679079
[TBL] [Abstract][Full Text] [Related]
36. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
Fangmann J; Dalchau R; Fabre JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
[No Abstract] [Full Text] [Related]
37. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
39. Frequency of alloantigen-specific T cytotoxic cells in high- and low-responder recipients of class I MHC-disparate heart allografts.
Stepkowski SM; Ito T
Transplantation; 1990 Jul; 50(1):112-9. PubMed ID: 2368131
[TBL] [Abstract][Full Text] [Related]
40. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
